Knowledge Management System of Hefei Institute of Physical Science,CAS
Programmable Repurposing of Existing Drugs as Pharmaceutical Elements for the Construction of Aptamer-Drug Conjugates | |
Gao, Fei1,2,3; Zhou, Jinming4; Sun, Yang1,2; Yang, Cai1,2; Zhang, Shiyan1,2; Wang, Ruowen1,2; Tan, Weihong1,2,5 | |
2021-03-03 | |
发表期刊 | ACS APPLIED MATERIALS & INTERFACES |
ISSN | 1944-8244 |
通讯作者 | Wang, Ruowen(wangwrw@sjtu.edu.cn) ; Tan, Weihong(tan@hnu.edu.cn) |
摘要 | Converting marketed drug molecules into phos-phoramidites may present a potential strategy to facilitate the development of aptamer-drug conjugates (ApDCs) by a DNA synthesizer in a programmable way; however, quite limited methods were reported. Herein, we demonstrated a general approach by repurposing camptothecin (CPT) species. Commonly used inactive ingredients in pharmaceuticals are investigated and selected as a bonding moiety, from which 2-mercaptoethoxy ethanol and thioglycerol were efficiently incorporated with CPT to give the precursors. Cell viability and molecular docking results of the precursors supported that incorporation of the bonding moiety would not interrupt the inhibitory activity. Therefore, corresponding phosphoramidites were prepared as pharmaceutical elements, and a series of ApDCs were constructed automatically by solid-phase synthesis. Biological studies revealed that CPT elements could be specifically delivered to HCT116 cells by an aptamer and released inside cells. This kind of programmable repurposing may take advantage of established safety data and efficacy of existing drugs resulting in a faster development of ApDCs. |
关键词 | aptamer pharmaceutical elements solid-phase synthesis targeted therapy drug delivery |
DOI | 10.1021/acsami.0c18846 |
收录类别 | SCI |
语种 | 英语 |
资助项目 | National Science Foundation of China[21877079] ; National Science Foundation of China[81803068] |
项目资助者 | National Science Foundation of China |
WOS研究方向 | Science & Technology - Other Topics ; Materials Science |
WOS类目 | Nanoscience & Nanotechnology ; Materials Science, Multidisciplinary |
WOS记录号 | WOS:000626502700022 |
出版者 | AMER CHEMICAL SOC |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.hfcas.ac.cn:8080/handle/334002/121087 |
专题 | 中国科学院合肥物质科学研究院 |
通讯作者 | Wang, Ruowen; Tan, Weihong |
作者单位 | 1.Shanghai Jiao Tong Univ, Inst Mol Med IMM, State Key Lab Oncogenes & Related Genes, Renji Hosp,Sch Med, Shanghai 200240, Peoples R China 2.Shanghai Jiao Tong Univ, Coll Chem & Chem Engn, Shanghai 200240, Peoples R China 3.Shanghai Univ, Inst Translat Med, Shanghai 200444, Peoples R China 4.Zhejiang Normal Univ, Dept Chem, Key Lab, Minist Educ Adv Catalysis Mat, 688 Yingbin Rd, Jinhua 321004, Zhejiang, Peoples R China 5.Univ Chinese Acad Sci, Chinese Acad Sci, Inst Basic Med & Canc IBMC, Canc Hosp, Hangzhou 310022, Zhejiang, Peoples R China |
推荐引用方式 GB/T 7714 | Gao, Fei,Zhou, Jinming,Sun, Yang,et al. Programmable Repurposing of Existing Drugs as Pharmaceutical Elements for the Construction of Aptamer-Drug Conjugates[J]. ACS APPLIED MATERIALS & INTERFACES,2021,13. |
APA | Gao, Fei.,Zhou, Jinming.,Sun, Yang.,Yang, Cai.,Zhang, Shiyan.,...&Tan, Weihong.(2021).Programmable Repurposing of Existing Drugs as Pharmaceutical Elements for the Construction of Aptamer-Drug Conjugates.ACS APPLIED MATERIALS & INTERFACES,13. |
MLA | Gao, Fei,et al."Programmable Repurposing of Existing Drugs as Pharmaceutical Elements for the Construction of Aptamer-Drug Conjugates".ACS APPLIED MATERIALS & INTERFACES 13(2021). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论